Ziying Fei

912 total citations
17 papers, 755 citations indexed

About

Ziying Fei is a scholar working on Immunology, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Ziying Fei has authored 17 papers receiving a total of 755 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 7 papers in Biomedical Engineering and 6 papers in Molecular Biology. Recurrent topics in Ziying Fei's work include Immunotherapy and Immune Responses (7 papers), Extracellular vesicles in disease (5 papers) and Nanoplatforms for cancer theranostics (5 papers). Ziying Fei is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), Extracellular vesicles in disease (5 papers) and Nanoplatforms for cancer theranostics (5 papers). Ziying Fei collaborates with scholars based in China, United States and Japan. Ziying Fei's co-authors include Chao Wang, Jialu Xu, Qin Fan, Qingle Ma, Huaxing Dai, Yue Zhang, Zhuang Liu, Jinyu Bai, Fang Xu and Qianyu Yang and has published in prestigious journals such as Advanced Materials, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Ziying Fei

17 papers receiving 750 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ziying Fei China 13 377 302 254 138 110 17 755
Peter Abdou United States 7 313 0.8× 227 0.8× 175 0.7× 122 0.9× 166 1.5× 7 690
Hathaichanok Phuengkham United States 11 572 1.5× 308 1.0× 503 2.0× 301 2.2× 161 1.5× 17 955
Jingdong Rao China 15 425 1.1× 237 0.8× 141 0.6× 89 0.6× 278 2.5× 21 735
Jason S. Buhrman United States 13 166 0.4× 288 1.0× 142 0.6× 148 1.1× 136 1.2× 16 938
Kazuto Fukunaga Japan 10 187 0.5× 243 0.8× 214 0.8× 220 1.6× 226 2.1× 10 783
Michael Fichter Germany 13 185 0.5× 252 0.8× 261 1.0× 257 1.9× 148 1.3× 30 781
Wei‐Yun Lai Taiwan 18 287 0.8× 500 1.7× 121 0.5× 167 1.2× 208 1.9× 29 1.1k
Yuyue Zhao China 15 198 0.5× 246 0.8× 210 0.8× 117 0.8× 64 0.6× 31 682
Matthew Lin United States 6 288 0.8× 340 1.1× 524 2.1× 387 2.8× 101 0.9× 10 899
Aslan Mansurov United States 13 200 0.5× 248 0.8× 384 1.5× 351 2.5× 85 0.8× 18 808

Countries citing papers authored by Ziying Fei

Since Specialization
Citations

This map shows the geographic impact of Ziying Fei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziying Fei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziying Fei more than expected).

Fields of papers citing papers by Ziying Fei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ziying Fei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziying Fei. The network helps show where Ziying Fei may publish in the future.

Co-authorship network of co-authors of Ziying Fei

This figure shows the co-authorship network connecting the top 25 collaborators of Ziying Fei. A scholar is included among the top collaborators of Ziying Fei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ziying Fei. Ziying Fei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Xu, Fang, Jialu Xu, Huaxing Dai, et al.. (2023). Engineering of dendritic cell bispecific extracellular vesicles for tumor-targeting immunotherapy. Cell Reports. 42(10). 113138–113138. 20 indexed citations
2.
Xu, Jialu, Qingle Ma, Yue Zhang, et al.. (2022). Yeast-derived nanoparticles remodel the immunosuppressive microenvironment in tumor and tumor-draining lymph nodes to suppress tumor growth. Nature Communications. 13(1). 110–110. 90 indexed citations
3.
Wang, Beilei, Jinyu Bai, Bo Tian, et al.. (2022). Genetically Engineered Hematopoietic Stem Cells Deliver TGF‐β Inhibitor to Enhance Bone Metastases Immunotherapy. Advanced Science. 9(28). e2201451–e2201451. 18 indexed citations
5.
Ma, Qingle, Jinyu Bai, Jialu Xu, et al.. (2021). Reshaping the Inflammatory Environment in Rheumatoid Arthritis Joints by Targeting Delivery of Berberine with Platelet‐Derived Extracellular Vesicles. SHILAP Revista de lepidopterología. 1(11). 13 indexed citations
6.
Fan, Qin, Huaxing Dai, Jinyu Bai, et al.. (2021). Degradation-resistant implanted biomaterials establish an immunosuppressive microenvironment that induces T cell exhaustion by recruiting myeloid cells. Fundamental Research. 2(4). 648–658. 11 indexed citations
7.
Fei, Ziying, Qin Fan, Huaxing Dai, et al.. (2021). Physiologically triggered injectable red blood cell-based gel for tumor photoablation and enhanced cancer immunotherapy. Biomaterials. 271. 120724–120724. 41 indexed citations
8.
Dai, Huaxing, Qin Fan, Ziying Fei, et al.. (2021). Systemically administered silica nanoparticles result in diminished T cell response in lung. Nano Today. 42. 101332–101332. 10 indexed citations
9.
Ma, Qingle, Jinyu Bai, Jialu Xu, et al.. (2021). Reshaping the Inflammatory Environment in Rheumatoid Arthritis Joints by Targeting Delivery of Berberine with Platelet‐Derived Extracellular Vesicles. SHILAP Revista de lepidopterología. 1(11). 17 indexed citations
10.
Shen, Shufang, Huaxing Dai, Ziying Fei, et al.. (2021). Immunosuppressive Nanoparticles for Management of Immune-Related Adverse Events in Liver. ACS Nano. 15(5). 9111–9125. 37 indexed citations
11.
Ma, Qingle, Jialu Xu, Huaxing Dai, et al.. (2021). Targeted delivery of dexamethasone in acute pneumonia. Biomaterials Science. 9(16). 5569–5576. 16 indexed citations
12.
Xu, Fang, Ziying Fei, Huaxing Dai, et al.. (2021). Mesenchymal Stem Cell‐Derived Extracellular Vesicles with High PD‐L1 Expression for Autoimmune Diseases Treatment. Advanced Materials. 34(1). e2106265–e2106265. 127 indexed citations
13.
Zhang, Yue, Jialu Xu, Ziying Fei, et al.. (2021). 3D Printing Scaffold Vaccine for Antitumor Immunity (Adv. Mater. 48/2021). Advanced Materials. 33(48). 3 indexed citations
14.
Zhang, Yue, Jialu Xu, Ziying Fei, et al.. (2021). 3D Printing Scaffold Vaccine for Antitumor Immunity. Advanced Materials. 33(48). e2106768–e2106768. 81 indexed citations
15.
Fan, Qin, Jinyu Bai, Huajian Shan, et al.. (2021). Implantable blood clot loaded with BMP-2 for regulation of osteoimmunology and enhancement of bone repair. Bioactive Materials. 6(11). 4014–4026. 57 indexed citations
16.
Chen, Hao, Bo Tian, Jinyu Bai, et al.. (2021). Injectable Erythrocyte Gel Loaded with Bulleyaconitine A for the Treatment of Rheumatoid Arthritis. ACS Biomaterials Science & Engineering. 7(12). 5706–5716. 12 indexed citations
17.
Fan, Qin, Qingle Ma, Jialu Xu, et al.. (2020). An implantable blood clot–based immune niche for enhanced cancer vaccination. Science Advances. 6(39). 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026